Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States.
Rhodes NJ, Dairem A, Moore WJ, Shah A, Postelnick MJ, Badowski ME, Michienzi SM, Borkowski JL, Polisetty RS, Fong K, Spivak ES, Beardsley JR, Hale CM, Pallotta AM, Srinivas P, Schulz LT. Rhodes NJ, et al. Among authors: moore wj. Am J Health Syst Pharm. 2021 Mar 18;78(7):568-577. doi: 10.1093/ajhp/zxaa426. Am J Health Syst Pharm. 2021. PMID: 33537767 Free PMC article.
Characterizing Risk Factors for Clostridioides difficile Infection among Hospitalized Patients with Community-Acquired Pneumonia.
Rhodes NJ, Jozefczyk CC, Moore WJ, Yarnold PR, Harkabuz K, Maxwell R, Sutton SH, Silkaitis C, Qi C, Wunderink RG, Zembower TR. Rhodes NJ, et al. Among authors: moore wj. Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0041721. doi: 10.1128/AAC.00417-21. Epub 2021 Jun 17. Antimicrob Agents Chemother. 2021. PMID: 33875439 Free PMC article.
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
Alosaimy S, Lagnf AM, Hobbs ALV, Mubarez M, Kufel WD, Morrisette T, Polisetty RS, Li D, Veve MP, Simon SP, Truong J, Finch N, Venugopalan V, Rico M, Amaya L, Yost C, Cubillos A, Chandler E, Patch M, Smith IMK, Biagi M, Wrin J, Moore WJ, Molina KC, Rebold N, Holger D, Kunz Coyne AJ, Jorgensen SCJ, Witucki P, Tran NN, Davis SL, Sakoulas G, Rybak MJ. Alosaimy S, et al. Among authors: moore wj. Clin Infect Dis. 2023 Feb 8;76(3):e1444-e1455. doi: 10.1093/cid/ciac670. Clin Infect Dis. 2023. PMID: 35982631
Disparities in COVID-19 Monoclonal Antibody Delivery: a Retrospective Cohort Study.
Wu EL, Kumar RN, Moore WJ, Hall GT, Vysniauskaite I, Kim KA, Angarone MP, Stosor V, Ison MG, Bba AF, Achenbach CJ, Gates KL. Wu EL, et al. Among authors: moore wj. J Gen Intern Med. 2022 Aug;37(10):2505-2513. doi: 10.1007/s11606-022-07603-4. Epub 2022 Apr 25. J Gen Intern Med. 2022. PMID: 35469360 Free PMC article. Review.
How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases Pharmacists.
Cole KA, Zhou AY, Jones T, Moore WJ, Chandler EL, Zafonte VB, Morrisette T, Gauthier TP, Kisgen J, Barner A, Johnson MD, Tagare RD, Justo JA. Cole KA, et al. Among authors: moore wj. Clin Infect Dis. 2022 May 15;74(Suppl_3):e23-e33. doi: 10.1093/cid/ciac081. Clin Infect Dis. 2022. PMID: 35568481 Free PMC article.
251 results